Multicentric Database for KRAS Mutant Pancreatic Cancer
Recruiting · NCT07557849 · Observational (researchers observe without assigning treatment) · Lead sponsor: Fudan University
View the official record on ClinicalTrials.gov →What this trial is about
Construction and Maintenance of a Precision Subtyping-Based Clinical Cohort for Targeted Therapy in KRAS-Mutant Pancreatic Cancer
Who can take part
Age range
No age limits stated
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- No restrictions on age, gender, or performance status score;
- Pathologically or cytologically confirmed pancreatic adenocarcinoma; ③ Known KRAS mutation subtype and has received treatment with KRAS-targeted agents;
- ④ Able to comply with the study visit schedule requirements;
- ⑤ Voluntarily participate and sign the informed consent form.
Exclusion criteria
- Non-neoplastic pancreatic lesions;
- Non-primary pancreatic neoplastic lesions; ③ Unable to comply with the study visit schedule requirements; ④ Refuse to participate and sign the informed consent form.
Where it is running
1 location listed.
- Department of Pancreatic Surgery - Shanghai, China